These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34353538)

  • 1. Factor XI Inhibition to Uncouple Thrombosis From Hemostasis: JACC Review Topic of the Week.
    Hsu C; Hutt E; Bloomfield DM; Gailani D; Weitz JI
    J Am Coll Cardiol; 2021 Aug; 78(6):625-631. PubMed ID: 34353538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor XI and XII as antithrombotic targets.
    Müller F; Gailani D; Renné T
    Curr Opin Hematol; 2011 Sep; 18(5):349-55. PubMed ID: 21730835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis: Factor XI as a Target for New Anticoagulants.
    Weitz JI; Fredenburgh JC
    Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):304-310. PubMed ID: 29269514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XI and factor XII as targets for new anticoagulants.
    Weitz JI
    Thromb Res; 2016 May; 141 Suppl 2():S40-5. PubMed ID: 27207423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hemostatic role of factor XI.
    Puy C; Rigg RA; McCarty OJ
    Thromb Res; 2016 May; 141 Suppl 2(Suppl 2):S8-S11. PubMed ID: 27207433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new strategy for anticoagulation: The factor XI inhibitors.
    Vedovati MC; Becattini C; Agnelli G
    Eur J Intern Med; 2023 Oct; 116():8-15. PubMed ID: 37544845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Evaluation of Factor XIa Inhibitor Drugs: JACC Review Topic of the Week.
    Harrington J; Piccini JP; Alexander JH; Granger CB; Patel MR
    J Am Coll Cardiol; 2023 Feb; 81(8):771-779. PubMed ID: 36813377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XI as a Target for New Anticoagulants.
    Fredenburgh JC; Weitz JI
    Hamostaseologie; 2021 Apr; 41(2):104-110. PubMed ID: 33860518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrinsic pathway of coagulation and arterial thrombosis.
    Gailani D; Renné T
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct oral anticoagulant (DOAC) interference in hemostasis assays.
    Moser KA; Smock KJ
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):129-133. PubMed ID: 34889400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation.
    Barnes GD; Ageno W; Castellucci LA; Chiasakul T; Eslick R; Ferreiro JL; Gailani D; Gorog DA; Lip GYH; Raffini L; Rezende SM; Weitz JI; Cuker A
    J Thromb Haemost; 2023 May; 21(5):1381-1384. PubMed ID: 36796485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XI inhibitors: cardiovascular perspectives.
    De Caterina R; Prisco D; Eikelboom JW
    Eur Heart J; 2023 Jan; 44(4):280-292. PubMed ID: 36263776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a novel selective factor Xa inhibitor, DJT06001, which reduces thrombus formation with low risk of bleeding.
    Hu X; Xiao Y; Yu C; Zuo Y; Yang W; Wang X; Gu B; Li J
    Eur J Pharmacol; 2018 Apr; 825():85-91. PubMed ID: 29475063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of new anticoagulant in 2023: Prime time for anti-factor XI and XIa inhibitors.
    Bentounes NK; Melicine S; Martin AC; Smadja DM; Gendron N
    J Med Vasc; 2023 Apr; 48(2):69-80. PubMed ID: 37422330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology and Clinical Development of Factor XI Inhibitors.
    Greco A; Laudani C; Spagnolo M; Agnello F; Faro DC; Finocchiaro S; Legnazzi M; Mauro MS; Mazzone PM; Occhipinti G; Rochira C; Scalia L; Capodanno D
    Circulation; 2023 Mar; 147(11):897-913. PubMed ID: 36913497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XI as a target for antithrombotic therapy.
    Bane CE; Gailani D
    Drug Discov Today; 2014 Sep; 19(9):1454-8. PubMed ID: 24886766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New anticoagulants in 2024: Development of factor XI and XIa inhibitors].
    Bentounes NK; Melicine S; Martin AC; Smadja DM; Gendron N
    Ann Biol Clin (Paris); 2024 Apr; 82(1):9-23. PubMed ID: 38638015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation beyond direct thrombin and factor Xa inhibitors: indications for targeting the intrinsic pathway?
    van Montfoort ML; Meijers JC
    Thromb Haemost; 2013 Aug; 110(2):223-32. PubMed ID: 23739841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XI(a) inhibitors for thrombosis: an updated patent review (2016-present).
    Al-Horani RA
    Expert Opin Ther Pat; 2020 Jan; 30(1):39-55. PubMed ID: 31847619
    [No Abstract]   [Full Text] [Related]  

  • 20. A rapid pro-hemostatic approach to overcome direct oral anticoagulants.
    Thalji NK; Ivanciu L; Davidson R; Gimotty PA; Krishnaswamy S; Camire RM
    Nat Med; 2016 Aug; 22(8):924-32. PubMed ID: 27455511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.